Loading...
Loading...
Jefferies & Co. is out with a research report on Health Care REIT
HCN and it is raising its price target to $52 from $48, and it has a Hold rating on shares.
In a note to clients, Jefferies & Co. writes, "While we believe HCN is well-positioned to grow FFO/sh by 10%+ in 2012, we believe the shares are fairly valued at current levels given HCN's risk-reward profile. As such, we maintain our Hold rating on HCN shares."
Shares of HCN are off 10 cents to $49.90 today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in